Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Share-based Compensation (2016 - 2019)

Historic Share-based Compensation for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $204000.0.

  • Soleno Therapeutics' Share-based Compensation fell 6007.83% to $204000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $825000.0, marking a year-over-year decrease of 3653.85%. This contributed to the annual value of $100.0 million for FY2024, which is 158208.58% up from last year.
  • Soleno Therapeutics' Share-based Compensation amounted to $204000.0 in Q4 2019, which was down 6007.83% from $153000.0 recorded in Q3 2019.
  • In the past 5 years, Soleno Therapeutics' Share-based Compensation ranged from a high of $511000.0 in Q4 2018 and a low of $136000.0 during Q1 2016
  • In the last 5 years, Soleno Therapeutics' Share-based Compensation had a median value of $212000.0 in 2016 and averaged $246882.0.
  • As far as peak fluctuations go, Soleno Therapeutics' Share-based Compensation skyrocketed by 392000.0% in 2015, and later tumbled by 6608.48% in 2016.
  • Over the past 5 years, Soleno Therapeutics' Share-based Compensation (Quarter) stood at $196369.0 in 2015, then surged by 58.51% to $311270.0 in 2016, then crashed by 53.42% to $145000.0 in 2017, then skyrocketed by 252.41% to $511000.0 in 2018, then crashed by 60.08% to $204000.0 in 2019.
  • Its Share-based Compensation was $204000.0 in Q4 2019, compared to $153000.0 in Q3 2019 and $220000.0 in Q2 2019.